Shedding light on the FDA's 510(k) approvals process: low-level laser therapy devices used in the treatment of androgenetic alopecia

Sophie Wang, Divya Seth, Harib Ezaldein, Raghav Tripathi, Miesha Merati, Fuad Muakkassa, Jeffrey Scott

Research output: Contribution to journalLetter

Abstract

Introduction: Low-level laser therapy has demonstrated superior efficacy relative to other nonsurgical treatment options for the treatment of androgenetic alopecia. Methods: Records from a public U.S. FDA database for premarket approval of low-level laser therapy devices approved between January 1 2000 and July 15 2018 were reviewed. Results: 47 devices received 510(k) premarket approval, with an increasing number of devices available since 2007. More options are now available and product indications have expanded for use in a wider audience, including both men and women. Discussion: Growing recognition of lasers has led to an increasing number of devices available as well as innovative options in terms of design and convenience. In the past few years, these devices have adopted broader indications for use in both men and women. However, marketed indications have not been adequately explored and current devices on the market have the potential to mislead consumers.

Original languageEnglish (US)
Pages (from-to)489-491
Number of pages3
JournalJournal of Dermatological Treatment
Volume30
Issue number5
DOIs
StatePublished - Jul 4 2019
Externally publishedYes

Fingerprint

Alopecia
Equipment and Supplies
Therapeutics
Low-Level Light Therapy
Lasers
Databases

Keywords

  • 510(k)
  • Androgenetic alopecia
  • hair growth
  • hair loss
  • low-level laser therapy

ASJC Scopus subject areas

  • Dermatology

Cite this

Shedding light on the FDA's 510(k) approvals process : low-level laser therapy devices used in the treatment of androgenetic alopecia. / Wang, Sophie; Seth, Divya; Ezaldein, Harib; Tripathi, Raghav; Merati, Miesha; Muakkassa, Fuad; Scott, Jeffrey.

In: Journal of Dermatological Treatment, Vol. 30, No. 5, 04.07.2019, p. 489-491.

Research output: Contribution to journalLetter

Wang, Sophie ; Seth, Divya ; Ezaldein, Harib ; Tripathi, Raghav ; Merati, Miesha ; Muakkassa, Fuad ; Scott, Jeffrey. / Shedding light on the FDA's 510(k) approvals process : low-level laser therapy devices used in the treatment of androgenetic alopecia. In: Journal of Dermatological Treatment. 2019 ; Vol. 30, No. 5. pp. 489-491.
@article{563a57590a2e4140bd8b2b0eb2e3a84e,
title = "Shedding light on the FDA's 510(k) approvals process: low-level laser therapy devices used in the treatment of androgenetic alopecia",
abstract = "Introduction: Low-level laser therapy has demonstrated superior efficacy relative to other nonsurgical treatment options for the treatment of androgenetic alopecia. Methods: Records from a public U.S. FDA database for premarket approval of low-level laser therapy devices approved between January 1 2000 and July 15 2018 were reviewed. Results: 47 devices received 510(k) premarket approval, with an increasing number of devices available since 2007. More options are now available and product indications have expanded for use in a wider audience, including both men and women. Discussion: Growing recognition of lasers has led to an increasing number of devices available as well as innovative options in terms of design and convenience. In the past few years, these devices have adopted broader indications for use in both men and women. However, marketed indications have not been adequately explored and current devices on the market have the potential to mislead consumers.",
keywords = "510(k), Androgenetic alopecia, hair growth, hair loss, low-level laser therapy",
author = "Sophie Wang and Divya Seth and Harib Ezaldein and Raghav Tripathi and Miesha Merati and Fuad Muakkassa and Jeffrey Scott",
year = "2019",
month = "7",
day = "4",
doi = "10.1080/09546634.2018.1528327",
language = "English (US)",
volume = "30",
pages = "489--491",
journal = "Journal of Dermatological Treatment",
issn = "0954-6634",
publisher = "Informa Healthcare",
number = "5",

}

TY - JOUR

T1 - Shedding light on the FDA's 510(k) approvals process

T2 - low-level laser therapy devices used in the treatment of androgenetic alopecia

AU - Wang, Sophie

AU - Seth, Divya

AU - Ezaldein, Harib

AU - Tripathi, Raghav

AU - Merati, Miesha

AU - Muakkassa, Fuad

AU - Scott, Jeffrey

PY - 2019/7/4

Y1 - 2019/7/4

N2 - Introduction: Low-level laser therapy has demonstrated superior efficacy relative to other nonsurgical treatment options for the treatment of androgenetic alopecia. Methods: Records from a public U.S. FDA database for premarket approval of low-level laser therapy devices approved between January 1 2000 and July 15 2018 were reviewed. Results: 47 devices received 510(k) premarket approval, with an increasing number of devices available since 2007. More options are now available and product indications have expanded for use in a wider audience, including both men and women. Discussion: Growing recognition of lasers has led to an increasing number of devices available as well as innovative options in terms of design and convenience. In the past few years, these devices have adopted broader indications for use in both men and women. However, marketed indications have not been adequately explored and current devices on the market have the potential to mislead consumers.

AB - Introduction: Low-level laser therapy has demonstrated superior efficacy relative to other nonsurgical treatment options for the treatment of androgenetic alopecia. Methods: Records from a public U.S. FDA database for premarket approval of low-level laser therapy devices approved between January 1 2000 and July 15 2018 were reviewed. Results: 47 devices received 510(k) premarket approval, with an increasing number of devices available since 2007. More options are now available and product indications have expanded for use in a wider audience, including both men and women. Discussion: Growing recognition of lasers has led to an increasing number of devices available as well as innovative options in terms of design and convenience. In the past few years, these devices have adopted broader indications for use in both men and women. However, marketed indications have not been adequately explored and current devices on the market have the potential to mislead consumers.

KW - 510(k)

KW - Androgenetic alopecia

KW - hair growth

KW - hair loss

KW - low-level laser therapy

UR - http://www.scopus.com/inward/record.url?scp=85057270480&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057270480&partnerID=8YFLogxK

U2 - 10.1080/09546634.2018.1528327

DO - 10.1080/09546634.2018.1528327

M3 - Letter

C2 - 30252550

AN - SCOPUS:85057270480

VL - 30

SP - 489

EP - 491

JO - Journal of Dermatological Treatment

JF - Journal of Dermatological Treatment

SN - 0954-6634

IS - 5

ER -